Literature DB >> 16426736

Expression of COX-2 in normal and pyelonephritic kidney, renal intraepithelial neoplasia, and renal cell carcinoma.

M Ugur Mungan1, Duygu Gurel, A Erdem Canda, Burcin Tuna, Kutsal Yorukoglu, Ziya Kirkali.   

Abstract

OBJECTIVES: The role of inflammation in carcinogenesis is unknown. To determine the relationship between cyclooxygenase 2 (COX-2) expression, inflammation, and carcinogenesis in human renal cell carcinoma (RCC), we looked for COX-2 expression in normal and pyelonephritic kidney, renal intratubular neoplasia (RIN), and RCC tissues.
METHODS: COX-2 expression was assessed immunohistochemically in tissues obtained from 20 pyelonephritic kidneys, 16 normal kidneys, 19 RIN, and 75 RCC cases.
RESULTS: COX-2 expression was found to be positive in 64% of RCCs. It was positive in 13 chronic pyelonephritic (65%), 9 normal (56%), and 15 RIN (79%) cases. COX-2 expression was significantly higher in RCC and RIN than the normal and pyelonephritic cases (p<0.001 and p<0.001, respectively). No statistically significant difference was noted between RCC and RIN cases.
CONCLUSIONS: Although the function of COX-2 in tumor development has not been exactly elucidated, the increased expression of COX-2 in RIN and RCC might be a factor that may play a role in the development of RIN or progression to RCC, which warrants further research.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16426736     DOI: 10.1016/j.eururo.2005.12.039

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  8 in total

1.  Prostaglandin E2 regulates renal cell carcinoma invasion through the EP4 receptor-Rap GTPase signal transduction pathway.

Authors:  Juanjuan Wu; Yushan Zhang; Nicole Frilot; Jae I Kim; Wan-Ju Kim; Yehia Daaka
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

2.  Role of inflammatory related gene expression in clear cell renal cell carcinoma development and clinical outcomes.

Authors:  Weiqi Tan; Michelle A T Hildebrandt; Xia Pu; Maosheng Huang; Jie Lin; Surena F Matin; Pheroze Tamboli; Christopher G Wood; Xifeng Wu
Journal:  J Urol       Date:  2011-09-23       Impact factor: 7.450

Review 3.  The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma.

Authors:  Sunao Shoji; Mayura Nakano; Haruhiro Sato; Xian Yang Tang; Yoshiyuki Robert Osamura; Toshiro Terachi; Toyoaki Uchida; Koichi Takeya
Journal:  Clin Exp Metastasis       Date:  2014-01       Impact factor: 5.150

4.  Relationship between arachidonic acid pathway and human renal cell carcinoma.

Authors:  Masahide Matsuyama; Rikio Yoshimura
Journal:  Onco Targets Ther       Date:  2008-10-01       Impact factor: 4.147

Review 5.  Metabolic reprogramming in renal cancer: Events of a metabolic disease.

Authors:  Samik Chakraborty; Murugabaskar Balan; Akash Sabarwal; Toni K Choueiri; Soumitro Pal
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2021-05-06       Impact factor: 11.414

6.  Upregulation of family with sequence similarity 83 member D expression enhances cell proliferation and motility via activation of Wnt/β-catenin signaling and predicts poor prognosis in gastric cancer.

Authors:  Furong Wang; Sigong Zhang; Yucai Wei; Hao Chen; Zuoyi Jiao; Yumin Li
Journal:  Cancer Manag Res       Date:  2019-07-22       Impact factor: 3.989

7.  Cyclooxygenase-2 expression and its prognostic significance in clear cell renal cell carcinoma.

Authors:  Ji Won Lee; Jeong Hwan Park; Ja Hee Suh; Kyung Han Nam; Ji-Young Choe; Hae Yoen Jung; Ji Yoen Chae; Kyung Chul Moon
Journal:  Korean J Pathol       Date:  2012-06-22

8.  Cyclooxygenase in normal human tissues--is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?

Authors:  Nina Zidar; Katarina Odar; Damjan Glavac; Maja Jerse; Tomaz Zupanc; Dusan Stajer
Journal:  J Cell Mol Med       Date:  2008-07-24       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.